Thousand Plants against Cancer without Chemo-2010(1)

Inosmetzeff http://www.mednat.org/cancro/inosmetzeff.pdf ;http://www.mednat.org/cancro/inosmetzeff2.pdfIssels Joseph. MD, Germany (Keller, Helmut Stella Maris Clinic in Mexico.Kroiss, Thomas, M.D. in Vienna, Austria http://www.kroisscancercenter.com/Manner Harold, MD, Harold Manner CenterNagourney, Robert M.D. http://www.rationaltherapeutics.com/Pauling Linus http://www.paulingtherapy.com/Pesic, Milan M.D. (Germany)Privitera, James M.D http://www.nutriscreen.com/Revici, Emanuel M.D., Revici Life Science Center,Richardson, John “Laetrile case Histories; the Richardson Cancer Clinic Experience”(http://www.realityzone.com/lcm.html )Rizov, Vladimir M.D., www.newvitality.comRodriguez, Rodrigo M.D. http://www.ibchospital.com/Rossi Domenico M.D., http://fiocco59.altervista.org/vitamina_b_17.htmRoundtree, Robert M.D., Robert C. Roundtree, M.D.,Rowen, Robert M.D. http://www.doctorrowen.comRubio, Geronimo MD http://www.ami-health.com/http://www.cancure.org/american_metabolic.htm.Schachter, Michael B. M.D. http://www.mbschachter.comStoff, Jesse M.D., Immune Therapies International (ITI).Tasca, Marco M.D., http://www.mednat.org/cancro/tasca.pdf )Taylor, Lawrence, MD Lawrence H. Taylor, M.D.,Waisbren, Burton, M.D. www.waisbrenclinic.comWatayo, Takaho, M.D. TokyoYoshihiko, Hoshino, M.D. TokyoAlthough this high-dose vitamin therapy is based on specific scientific and medical knowledge, ithas been relegated to the field of “alternative” therapies owing to the commercial interests ofchemo-pharmaceutical lobbying groups: the question raised by the use of Laetrile for cancertreatment in the ’70s in the USA is an example of that (SEE chapter 7 of this E-Book).The European Commission (Internal Market, Tourism and Consumer Protection sections of theEuropean Union) has recently presented a proposal of a directive concerning vitamin integrators,natural and nutritional products in the European Union (SEE chapter 1 of this E-Book).The European Commission essentially wants to:1) limit strictly maximum doses of vitamin and mineral allowed in integrators (article 5 of theproposal for directive);2) eliminate from the market all sources of vitamins and minerals which are not contained in arestricted list of “allowed chemical substances”;3) eliminate herbal products from free marketization in Europe, with the obligation to be registeredas “herbal traditional medical products” (proposal of the Commission for a directive concerningherbal traditional medicines – 3th draft, May 2001);4) prohibit information about preventive and curative properties of vitamins and herbs, by declaringthis information illegal if connected in any way with a product.32